Florida-based company that deals with cancer diagnostics Oncosure announced on Wednesday that it has launched its Rapid Cancer Screening Test, making early detection accessible to everyone.
It is claimed that the Oncosure test can screen for all types of cancer with one blood sample and that it provides a method to detect cancer at its earliest stages, even as early as stage -1 and delivers accurate, definitive results within hours. The company says that it also helps in monitoring ongoing cancer treatments, helping assess whether therapies are effective.
Jason Andrews, Oncosure vice president, said, 'One blood draw, all cancers--this is the future of cancer screening. Cancer doesn't wait for symptoms, and neither should you. Our test empowers everyone to screen for any type of cancer with a single, non-invasive test.'
NeoGenomics to present breakthrough data at ESMO 2024 on ctDNA and NGS for cancer diagnostics
Pheon Therapeutics names new independent, non-executive director
Solu Therapeutics names new chief medical officer
Carisma and Moderna expand collaboration
OSE Immunotherapeutics initiates Phase 3 trial for cancer vaccine Tedopi
Phanes Therapeutics doses first subject in clinical study of PT886 in combination with chemotherapy
AbbVie advances solid tumour pipeline with new data at ESMO 2024
Amgen showcases promising data for IMDELLTRA in small cell lung cancer at WCLC 2024
Cantargia reports promising data for nadunolimab in cancer treatment
Hemogenyx Pharmaceuticals announces readiness of FLT3 assay for Phase I Trials at MD Anderson
Avacta announces presentation of updated data on AVA6000 at ESMO Congress 2024